(S)-nicotine increases expression ISO RGD:735310 6480464 Nicotine results in increased expression of PRKAR2B mRNA CTD PMID:18247414 1,2-dimethylhydrazine decreases expression ISO RGD:735311 6480464 1, 2-Dimethylhydrazine results in decreased expression of PRKAR2B mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:735311 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PRKAR2B mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of PRKAR2B mRNA CTD PMID:12832660 17alpha-ethynylestradiol affects expression ISO RGD:735311 6480464 Ethinyl Estradiol affects the expression of PRKAR2B mRNA CTD PMID:17555576 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of PRKAR2B mRNA CTD PMID:12655037 , PMID:15834898 17beta-estradiol multiple interactions ISO RGD:735310 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PRKAR2B mRNA CTD PMID:19619570 17beta-estradiol increases expression ISO RGD:735310 6480464 Estradiol results in increased expression of PRKAR2B mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:735310 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PRKAR2B mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PRKAR2B mRNA CTD PMID:32109520 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PRKAR2B mRNA CTD PMID:26232522 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:735310 6480464 Tetrachlorodibenzodioxin results in increased expression of PRKAR2B mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:735310 6480464 Tetrachlorodibenzodioxin results in decreased expression of PRKAR2B mRNA CTD PMID:19619570 2-naphthylamine increases expression ISO RGD:735310 6480464 2-Naphthylamine results in increased expression of PRKAR2B mRNA CTD PMID:18247414 3',5'-cyclic AMP multiple interactions EXP 6480464 Clozapine inhibits the reaction [Cyclic AMP binds to PRKAR2B protein], Haloperidol promotes the reaction [Cyclic AMP binds to PRKAR2B protein] CTD PMID:11907174 3-chloropropane-1,2-diol decreases expression ISO RGD:735311 6480464 alpha-Chlorohydrin results in decreased expression of PRKAR2B mRNA CTD PMID:33187795 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:735310 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PRKAR2B mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:735310 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PRKAR2B mRNA CTD PMID:27685785 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of PRKAR2B mRNA CTD PMID:24780913 8-Br-cAMP increases expression ISO RGD:735310 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PRKAR2B mRNA CTD PMID:22079614 8-Br-cAMP multiple interactions ISO RGD:735311 6480464 [monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of PRKAR2B protein CTD PMID:18467523 acetamide increases expression EXP 6480464 acetamide results in increased expression of PRKAR2B mRNA CTD PMID:31881176 aflatoxin B1 increases expression ISO RGD:735310 6480464 Aflatoxin B1 results in increased expression of PRKAR2B mRNA CTD PMID:32234424 aldehydo-D-glucose increases expression ISO RGD:735311 6480464 Glucose results in increased expression of PRKAR2B mRNA CTD PMID:17178593 aldehydo-D-glucose multiple interactions EXP 6480464 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside inhibits the reaction [[Oxygen co-treated with Glucose deficiency] results in decreased expression of PRKAR2B protein] more ... CTD PMID:24726522 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PRKAR2B mRNA CTD PMID:16483693 aristolochic acid A decreases expression ISO RGD:735310 6480464 aristolochic acid I results in decreased expression of PRKAR2B mRNA CTD PMID:33212167 arsane affects methylation ISO RGD:735310 6480464 Arsenic affects the methylation of PRKAR2B gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:735310 6480464 Arsenic affects the methylation of PRKAR2B gene CTD PMID:25304211 arsenite(3-) decreases expression ISO RGD:735311 6480464 arsenite results in decreased expression of PRKAR2B mRNA CTD PMID:18191166 arsenite(3-) increases expression ISO RGD:735311 6480464 arsenite results in increased expression of PRKAR2B mRNA CTD PMID:33053406 benzo[a]pyrene increases expression ISO RGD:735310 6480464 Benzo(a)pyrene results in increased expression of PRKAR2B mRNA CTD PMID:18247414 , PMID:20106945 benzo[a]pyrene affects methylation ISO RGD:735310 6480464 Benzo(a)pyrene affects the methylation of PRKAR2B promoter CTD PMID:27901495 bexarotene decreases expression EXP 6480464 bexarotene results in decreased expression of PRKAR2B mRNA CTD PMID:16648578 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of PRKAR2B mRNA CTD PMID:25181051 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PRKAR2B mRNA CTD PMID:30816183 bisphenol A increases expression ISO RGD:735310 6480464 bisphenol A results in increased expression of PRKAR2B mRNA, bisphenol A results in increased expression of PRKAR2B protein CTD PMID:29275510 , PMID:34186270 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PRKAR2B mRNA CTD PMID:25181051 Bisphenol B increases expression ISO RGD:735310 6480464 bisphenol B results in increased expression of PRKAR2B protein CTD PMID:34186270 butanal increases expression ISO RGD:735310 6480464 butyraldehyde results in increased expression of PRKAR2B mRNA CTD PMID:26079696 cantharidin increases expression ISO RGD:735311 6480464 Cantharidin results in increased expression of PRKAR2B mRNA CTD PMID:36907384 carbon nanotube decreases expression ISO RGD:735311 6480464 Nanotubes more ... CTD PMID:25554681 casticin decreases expression ISO RGD:735310 6480464 casticin results in decreased expression of PRKAR2B mRNA CTD PMID:27862857 CGP 52608 multiple interactions ISO RGD:735310 6480464 CGP 52608 promotes the reaction [RORA protein binds to PRKAR2B gene] CTD PMID:28238834 chlordecone increases expression ISO RGD:735311 6480464 Chlordecone results in increased expression of PRKAR2B mRNA CTD PMID:33711761 chlorpyrifos affects expression EXP 6480464 Chlorpyrifos affects the expression of PRKAR2B mRNA CTD PMID:17452286 cisplatin decreases expression ISO RGD:735310 6480464 Cisplatin results in decreased expression of PRKAR2B mRNA CTD PMID:27392435 clozapine decreases expression EXP 6480464 Clozapine results in decreased expression of PRKAR2B mRNA, Clozapine results in decreased expression of PRKAR2B protein CTD PMID:11907174 , PMID:15860345 clozapine multiple interactions EXP 6480464 Clozapine inhibits the reaction [Cyclic AMP binds to PRKAR2B protein] CTD PMID:11907174 cobalt dichloride decreases expression ISO RGD:735310 6480464 cobaltous chloride results in decreased expression of PRKAR2B mRNA CTD PMID:19320972 copper atom multiple interactions ISO RGD:735310 6480464 [NSC 689534 binds to Copper] which results in decreased expression of PRKAR2B mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:735310 6480464 [NSC 689534 binds to Copper] which results in decreased expression of PRKAR2B mRNA CTD PMID:20971185 cyclosporin A decreases expression ISO RGD:735310 6480464 Cyclosporine results in decreased expression of PRKAR2B mRNA CTD PMID:20106945 D-glucose increases expression ISO RGD:735311 6480464 Glucose results in increased expression of PRKAR2B mRNA CTD PMID:17178593 D-glucose multiple interactions EXP 6480464 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside inhibits the reaction [[Oxygen co-treated with Glucose deficiency] results in decreased expression of PRKAR2B protein] more ... CTD PMID:24726522 dexamethasone increases expression ISO RGD:735311 6480464 Dexamethasone results in increased expression of PRKAR2B mRNA CTD PMID:22733784 dexamethasone multiple interactions ISO RGD:735310 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PRKAR2B mRNA CTD PMID:28628672 dexamethasone increases expression ISO RGD:735310 6480464 Dexamethasone results in increased expression of PRKAR2B mRNA CTD PMID:25047013 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of PRKAR2B mRNA CTD PMID:21266533 dioxygen multiple interactions EXP 6480464 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside inhibits the reaction [[Oxygen co-treated with Glucose deficiency] results in decreased expression of PRKAR2B protein] more ... CTD PMID:24726522 dioxygen multiple interactions ISO RGD:735311 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRKAR2B mRNA CTD PMID:30529165 diquat decreases expression ISO RGD:735311 6480464 Diquat results in decreased expression of PRKAR2B mRNA CTD PMID:36851058 doxorubicin affects expression ISO RGD:735310 6480464 Doxorubicin affects the expression of PRKAR2B mRNA CTD PMID:29803840 doxorubicin increases expression ISO RGD:735310 6480464 Doxorubicin results in increased expression of PRKAR2B mRNA CTD PMID:35524977 doxorubicin multiple interactions ISO RGD:735310 6480464 PRKAR2B protein inhibits the reaction [TDRG1 protein affects the reaction [Doxorubicin results in decreased expression of BCL2 protein]] more ... CTD PMID:35524977 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of PRKAR2B mRNA CTD PMID:20655511 folic acid decreases expression ISO RGD:735310 6480464 Folic Acid results in decreased expression of PRKAR2B mRNA CTD PMID:21867686 folic acid multiple interactions ISO RGD:735311 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PRKAR2B mRNA CTD PMID:22206623 folic acid decreases expression ISO RGD:735311 6480464 Folic Acid results in decreased expression of PRKAR2B mRNA CTD PMID:25629700 furan increases expression EXP 6480464 furan results in increased expression of PRKAR2B mRNA CTD PMID:27387713 glucose increases expression ISO RGD:735311 6480464 Glucose results in increased expression of PRKAR2B mRNA CTD PMID:17178593 glucose multiple interactions EXP 6480464 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside inhibits the reaction [[Oxygen co-treated with Glucose deficiency] results in decreased expression of PRKAR2B protein] more ... CTD PMID:24726522 glyphosate decreases expression ISO RGD:735311 6480464 glyphosate results in decreased expression of PRKAR2B protein CTD PMID:36173347 haloperidol multiple interactions EXP 6480464 Haloperidol promotes the reaction [Cyclic AMP binds to PRKAR2B protein] CTD PMID:11907174 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of PRKAR2B mRNA, Haloperidol results in increased expression of PRKAR2B protein CTD PMID:11907174 haloperidol decreases expression EXP 6480464 Haloperidol results in decreased expression of PRKAR2B mRNA CTD PMID:15860345 hypochlorous acid increases expression ISO RGD:735311 6480464 Hypochlorous Acid results in increased expression of PRKAR2B mRNA CTD PMID:19376150 indometacin multiple interactions ISO RGD:735310 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PRKAR2B mRNA CTD PMID:28628672 isoprenaline multiple interactions EXP 6480464 natakalim inhibits the reaction [Isoproterenol results in decreased expression of PRKAR2B protein] CTD PMID:27890915 isoprenaline decreases expression EXP 6480464 Isoproterenol results in decreased expression of PRKAR2B protein CTD PMID:27890915 ivermectin decreases expression ISO RGD:735310 6480464 Ivermectin results in decreased expression of PRKAR2B protein CTD PMID:32959892 methylseleninic acid increases expression ISO RGD:735310 6480464 methylselenic acid results in increased expression of PRKAR2B mRNA CTD PMID:18548127 microcystin-LR increases methylation ISO RGD:735310 6480464 cyanoginosin LR results in increased methylation of PRKAR2B gene CTD PMID:29518473 microcystin-LR decreases expression ISO RGD:735310 6480464 cyanoginosin LR results in decreased expression of PRKAR2B mRNA CTD PMID:29518473 N(6)-butyryl-cAMP multiple interactions ISO RGD:735311 6480464 [monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of PRKAR2B protein CTD PMID:18467523 N-ethyl-N-nitrosourea increases expression EXP 6480464 Ethylnitrosourea results in increased expression of PRKAR2B mRNA CTD PMID:15954086 nickel sulfate increases expression ISO RGD:735310 6480464 nickel sulfate results in increased expression of PRKAR2B mRNA CTD PMID:22714537 nicotine increases expression ISO RGD:735310 6480464 Nicotine results in increased expression of PRKAR2B mRNA CTD PMID:18247414 ozone multiple interactions ISO RGD:735311 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PRKAR2B mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PRKAR2B mRNA CTD PMID:34911549 paracetamol affects expression ISO RGD:735311 6480464 Acetaminophen affects the expression of PRKAR2B mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of PRKAR2B mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:735310 6480464 Acetaminophen results in decreased expression of PRKAR2B mRNA CTD PMID:29067470 pentanal increases expression ISO RGD:735310 6480464 pentanal results in increased expression of PRKAR2B mRNA CTD PMID:26079696 PhIP increases expression ISO RGD:735310 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of PRKAR2B mRNA CTD PMID:20816883 pirinixic acid multiple interactions ISO RGD:735310 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PRKAR2B mRNA CTD PMID:19710929 potassium chromate increases expression ISO RGD:735310 6480464 potassium chromate(VI) results in increased expression of PRKAR2B mRNA CTD PMID:22714537 resveratrol increases expression ISO RGD:735311 6480464 resveratrol results in increased expression of PRKAR2B protein CTD PMID:25505154 Salidroside multiple interactions EXP 6480464 rhodioloside inhibits the reaction [[Oxygen co-treated with Glucose deficiency] results in decreased expression of PRKAR2B protein] CTD PMID:24726522 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of PRKAR2B protein CTD PMID:19072884 sodium arsenite increases expression ISO RGD:735311 6480464 sodium arsenite results in increased expression of PRKAR2B mRNA CTD PMID:31170414 succimer multiple interactions ISO RGD:735311 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PRKAR2B mRNA CTD PMID:26378955 sunitinib decreases expression ISO RGD:735310 6480464 Sunitinib results in decreased expression of PRKAR2B mRNA CTD PMID:31533062 taurine decreases expression ISO RGD:735310 6480464 Taurine results in decreased expression of PRKAR2B mRNA CTD PMID:16579726 testosterone decreases expression ISO RGD:735311 6480464 Testosterone results in decreased expression of PRKAR2B mRNA CTD PMID:19693291 testosterone increases expression ISO RGD:735311 6480464 Testosterone deficiency results in increased expression of PRKAR2B mRNA CTD PMID:33848595 testosterone enanthate affects expression EXP 6480464 testosterone enanthate affects the expression of PRKAR2B mRNA CTD PMID:25603467 tetrachloromethane affects expression ISO RGD:735311 6480464 Carbon Tetrachloride affects the expression of PRKAR2B mRNA CTD PMID:17484886 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of PRKAR2B mRNA CTD PMID:12832660 thapsigargin decreases expression EXP 6480464 Thapsigargin results in decreased expression of PRKAR2B protein CTD PMID:35544339 titanium dioxide decreases expression ISO RGD:735311 6480464 titanium dioxide results in decreased expression of PRKAR2B mRNA CTD PMID:23557971 topiramate decreases expression EXP 6480464 topiramate results in decreased expression of PRKAR2B mRNA CTD PMID:16979414 trichostatin A decreases expression ISO RGD:735310 6480464 trichostatin A results in decreased expression of PRKAR2B mRNA CTD PMID:24935251 triclosan decreases expression ISO RGD:735310 6480464 Triclosan results in decreased expression of PRKAR2B mRNA CTD PMID:30510588 Triptolide increases expression EXP 6480464 triptolide results in increased expression of PRKAR2B mRNA CTD PMID:23639586 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of PRKAR2B mRNA CTD PMID:21515302 undecane increases expression EXP 6480464 undecane results in increased expression of PRKAR2B protein CTD PMID:17337753 urethane increases expression ISO RGD:735310 6480464 Urethane results in increased expression of PRKAR2B mRNA CTD PMID:28818685 valproic acid increases expression ISO RGD:735310 6480464 Valproic Acid results in increased expression of PRKAR2B mRNA CTD PMID:19101580 more ... valproic acid decreases methylation ISO RGD:735310 6480464 Valproic Acid results in decreased methylation of PRKAR2B gene CTD PMID:29154799 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of PRKAR2B mRNA CTD PMID:23034163
